Roger Connor is a Mechanical and Manufacturing Engineering Graduate who then trained as a Chartered Accountant. He has been working in the Pharmaceutical industry for 21 years having spent two years with Astrazeneca and the last 19 years working in various parts of the Manufacturing organization within GSK. He has worked at sites in the UK and Ireland and has also held a number of central strategic roles. In 2008, he led a major restructuring of the Manufacturing organization and in 2009 he became Site Director at the Barnard Castle site in the North East of England, one of the largest sites in the GSK network. In 2010 he left Manufacturing and became head of Corporate Strategy for GSK working directly with the Corporate Executive team. Roger returned to manufacturing in 2012 when he was appointed President Designate Global Manufacturing and Supply (GMS). He assumed the role of President GMS in January 2013.